Trial of Neoadjuvant THP vs TCHP for HER2-Amplified/Positive Breast Cancer
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Yiduo Hu, MD
University of Kansas Medical Center
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
8 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- the University of Kansas Cancer Center (kucc)
Fairway, Kansas, United States
Recruiting - the University of Kansas Cancer Center - Westwood
Kansas City, Kansas, United States
Recruiting - Kucc - Indian Creek
Overland Park, Kansas, United States
Recruiting - Kucc - Overland Park
Overland Park, Kansas, United States
Recruiting - Kucc - Briarcliff
Westwood, Kansas, United States
Recruiting - Kucc - Olathe
Westwood, Kansas, United States
Recruiting - the University of Kansas Cancer Center - North
Kansas City, Missouri, United States
Recruiting - Kucc - Lee'S Summit
Lee's Summit, Missouri, United States
Recruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 14 Nov 2025
- Primary completion
- 14 Nov 2027
- Completion
- 14 May 2031
- Last update posted
- 6 May 2026
- Registered enrollment
- 100
- Registry id
- NCT07220135
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.